US2019125936A1PendingUtilityA1

Mesh-based in situ cross-linkable compositions

55
Assignee: LIFEBOND LTDPriority: May 9, 2016Filed: May 9, 2017Published: May 2, 2019
Est. expiryMay 9, 2036(~9.8 yrs left)· nominal 20-yr term from priority
C08L 2312/00C08L 89/00A61F 2/0063A61L 2300/254A61L 31/129A61L 31/146A61L 2300/80A61L 31/10A61L 2300/606
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A mesh-based composition comprising a cross-linkable protein or polypeptide and one or more cross-linking materials according to at least some embodiments.

Claims

exact text as granted — not AI-modified
1 . A mesh-based composition comprising a mesh and a coating, said coating comprising one or more cross-linkable protein or polypeptide and one or more cross-linking materials, wherein at least a portion of said mesh is coated with said coating and wherein the coated mesh composition comprises a self-adhering surgical mesh, which requires no additional fixation, and which is capable of minimizing tissue adhesions upon application. 
     
     
         2 . The composition of  claim 1 , wherein the mesh comprises a composite mesh, comprising a foamed composition of the cross-linkable protein or proteins and said one or more cross-linking materials. 
     
     
         3 . The composition of  claim 2 , wherein the composite mesh is in a sheet-like form. 
     
     
         4 . The composition of  claim 1 , wherein the cross-linkable protein or polypeptide comprises gelatin. 
     
     
         5 . The composition of  claim 4 , wherein the gelatin is foamed. 
     
     
         6 . The composition of  claim 5 , wherein the gelatin foam is in a density range of 1 to 100 mg/cm 3  and preferably in the range of 1 to 50 mg/cm 3 . 
     
     
         7 . The composition of  claim 1 , wherein said foamed gelatin comprises dried or lyophilized foamed gelatin. 
     
     
         8 . The composition of  claim 7 , wherein prior to foaming, the concentration of the gelatin solution is between 0.1% and 30% w/w. 
     
     
         9 . The composition of  claim 8 , wherein prior to foaming, the concentration of the gelatin solution is between 1% and 20% w/w. 
     
     
         10 . The composition of  claim 9 , wherein prior to foaming, the concentration of the gelatin solution is between 5% and 15% w/w. 
     
     
         11 . The composition of  claim 4 , wherein said one or more cross-linking materials comprise transglutaminase. 
     
     
         12 . The composition of  claim 1 , wherein the composite mesh features an incorporated surgical mesh. 
     
     
         13 . The composition of  claim 1 , comprising two sections, one of which is composed of a mesh enclosed within the adhesive composition and another which contains the adhesive composition alone, without mesh within it. 
     
     
         14 . The composition of  claim 1 , further comprising a non-sticky, protective backing. 
     
     
         15 . The composition of  claim 14 , wherein the backing comprises one or more cellulose ether derivatives, and/or crosslinked gelatin. 
     
     
         16 . The composition of  claim 15 , wherein said backing comprises HPMC (hydroxypropyl methylcellulose), HPC (hydroxypropyl cellulose), HEC (hydroxyethyl cellulose) or EC (ethyl cellulose). 
     
     
         17 . The composition of  claim 1 , comprising a non-adhesive backing layer, comprising a water-erodable, film-forming pharmaceutically acceptable polymer such as hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylmethyl cellulose, polyvinylalcohol, polyethylene glycol, polyethylene oxide, ethylene oxide-propylene oxide copolymers, collagen and derivatives, gelatin, albumin, polyaminoacids and derivatives, polyphosphazenes, polysaccharides and derivatives, chitin and chitosan, alone or in combination. 
     
     
         18 . The composition of  claim 14 , wherein said backing layer remains for up to 1 month following implantation. 
     
     
         19 . The composition of  claim 1 , wherein said one or more cross-linkable proteins comprises gelatin and further comprises a cross-linkable material selected from the group consisting of aminated PEG, aminated PVA, alginate and chitosan. 
     
     
         20 . The composition of  claim 1 , wherein only the mesh remains after one month following implantation. 
     
     
         21 . The composition of  claim 1 , wherein the mesh comprises a composite mesh, comprising a non-foamed composition of the cross-linkable protein or proteins and said one or more cross-linking materials. 
     
     
         22 - 120 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.